Cryo-Cell International I...

NASDAQ: CCEL · Real-Time Price · USD
4.42
0.31 (7.54%)
At close: Aug 15, 2025, 11:43 AM

Cryo-Cell International Cash Flow Statement

Financials in USD. Fiscal year is December - November.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Nov 30, 2024 Nov 30, 2023 Nov 30, 2022 Nov 30, 2021
Net Income
402.1K -9.52M 2.77M 2.08M
Depreciation & Amortization
1.02M 1.71M 1.81M 1.33M
Stock-Based Compensation
n/a 816.64K 461.35K 301.62K
Other Working Capital
5.69M -590.87K 5.37M 3.58M
Other Non-Cash Items
1.2M 16.68M 1.01M 1M
Deferred Income Tax
-309.27K -6.75M -1.73M -1.65M
Change in Working Capital
3.7M 5.99M 4.25M 4.86M
Operating Cash Flow
6.01M 8.92M 8.57M 7.93M
Capital Expenditures
-2.4M -7.64M -17.17M -6.95M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-2.89M -1.08M -1.14M n/a
Sales Maturities Of Investments
1.52M 577.14K 1.16M n/a
Other Investing Acitivies
-1.1M -800K 1.87M n/a
Investing Cash Flow
-4.88M -8.14M -15.28M -6.95M
Debt Repayment
2.16M -1.21M 9.29M -4.1M
Common Stock Repurchased
-1.42M -799.04K -1.82M -249.38K
Dividend Paid
-2.02M n/a -7.67M n/a
Other Financial Acitivies
304.4K -67.5K 354.77K 1.28M
Financial Cash Flow
-979.12K -2.07M 147.86K -3.07M
Net Cash Flow
154.89K -1.3M -6.56M -2.1M
Free Cash Flow
3.61M 1.28M -8.6M 974.92K